Causes of Death in Childhood Acute Lymphoblastic Leukemia at Hue Central Hospital for 10 Years (2008-2018)

Tran Kiem Hao1, Pham Nhu Hiep1, Nguyen Thi Kim Hoa1

  • 1Pediatric Center, Hue Central Hospital, Vietnam.

Global Pediatric Health
|February 8, 2020
PubMed

Insights

Infection is the leading cause of death in childhood acute lymphoblastic leukemia (ALL). Improving supportive care, particularly infection prevention and control, is crucial for better patient outcomes.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Infectious Diseases

Background:

  • Childhood acute lymphoblastic leukemia (ALL) remains a significant cause of pediatric cancer mortality.
  • Understanding the primary causes of death is essential for improving treatment protocols and patient survival rates.

Purpose of the Study:

  • To investigate the predominant causes of mortality among children diagnosed with acute lymphoblastic leukemia (ALL).
  • To identify specific factors contributing to death in pediatric ALL patients treated at Hue Central Hospital.

Main Methods:

  • A retrospective descriptive study was conducted on pediatric patients with ALL who died between 2008 and 2018.
  • Data were collected from medical records of 238 ALL patients, focusing on the causes and circumstances of death.

Main Results:

  • Infection was the leading cause of death in 43.2% of cases, with pneumonia being a common manifestation.
  • Relapse accounted for 27.0% of deaths, frequently occurring in the bone marrow and often early in the disease course.
  • Patients who died from infection often had an absolute neutrophil count below 500/µL, indicating severe immunosuppression.

Conclusions:

  • Infection is the primary driver of mortality in childhood acute lymphoblastic leukemia (ALL) patients in this cohort.
  • Enhanced supportive care, focusing on robust infection prevention and control strategies, is imperative to reduce ALL-related deaths.
  • Addressing early relapse and improving management of neutropenia are also critical for improving survival rates.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...